Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nouscom is a biotech company that develops a series of immunotherapies that are capable of selectively killing tumor cells.
MMI is a medical technology company that develops robotic systems for microsurgery and supermicrosurgery.
HighLife is a trans-catheter mitral valve replacement company.
Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Lhyfe is a producer and supplier of green hydrogen, generated through renewable energy sources.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Qovoltis offers smart charging solutions for electric vehicles and a mobile app for remote management.
Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
Mylight150 create of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.
Andera Partners has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Andera Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Medical Device. The firm invests across 24 different industry categories.
Among tracked funding rounds, Mineralys Therapeutics received $500.0M in a Post-IPO Debt round. Andera Partners's total known invested capital is $5.3B.
Andera Partners's average investment size is $81.9M across its portfolio of 65 companies.
Recent Andera Partners portfolio additions include Nouscom, MMI, HighLife, Cyllene Therapeutics, Mineralys Therapeutics. These companies were founded in 2020 or later.